Development and biopharmaceutical evaluation of osmotic pump tablets for controlled delivery of diclofenac sodium

Acta Pharmaceutica

Volumn 53, Issue 4, 2003, Pages 263-273

  Rani, Meena ^a,c   Surana, Rahul ^b   Sankar, Chelladurai ^a   Mishra, Brahmeshwar ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b 3M COMPANY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Bioavailability; Controlled release; Diclofenac sodium; Osmotic pump; Pharmacokinetics

Indexed keywords

CELLULOSE ACETATE; DICLOFENAC; DODECYL SULFATE SODIUM; MACROGOL 400; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; POTASSIUM BICARBONATE; POTASSIUM CHLORIDE; TALC;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED DRUG RELEASE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COATING; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; NORMAL HUMAN; OSMOTIC PUMP; PH; REGRESSION ANALYSIS; SUSTAINED RELEASE PREPARATION; TABLET; THICKNESS;

EID: 0345827825     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. T. Salsa, F. Veiga and M. E. Pina, Oral controlled release dosage forms I. Cellulose ether polymer in hydrophilic matrices, Drug Dev. Ind. Pharm. 23 (1997) 929-938.
2. F. Theeuwes, Drug delivery systems, Pharm. Ther. 13 (1981) 149-191.
3. B. Eckenhoff, F. Theeuwes and J. Urquhart, Osmotically activated dosage forms for rate controlled drug delivery, Pharm. Technol. 5 (1981) 35-44.
4. B. Eckenhoff and S. I. Yum, The osmotic pump; novel research tool for optimizing drug regimens, Biomaterials 2 (1981) 89-97.
5. C. Bindschaedler, R. Gurny and E. Doelker, Osmotically controlled drug delivery systems produced from organic solutions and aqueous dispersions of cellulose acetate, J. Contr. Rel. 4 (1986) 203-212.
6. R. K. Verma, B. Mishra and S. Garg, Osmotically controlled oral drug delivery, Drug Dev. Ind. Pharm. 26 (2000) 695-708.
7. R. K. Verma, D. M. Krishna and S. Garg, Formulation aspects in the developments of osmotically controlled oral drug delivery system, J. Contr. Rel. 79 (2002) 7-27.
8. G. Santus and R. W. Baker, Osmotic drug delivery; a review of patent literature, J. Contr. Rel. 35 (1995) 1-21.
9. R. K. Verma and B. Mishra, Studies on formulation and evaluation of oral osmotic pumps of nimesulide, Pharmazie 54 (1999) 74-75.
10. N. Ramakrishna and B. Mishra, Design and evaluation of osmotic pump tablets of naproxen sodium, Pharmazie 56 (2001) 958-962.
11. N. Ozdemir and J. Sahin, Design of a controlled release osmotic pump system of ibuprofen, Int. J. Pharm. 158 (1997) 91-97.
12. F. Theeuwes, Elementary osmotic pump, J. Pharm. Sci. 64 (1975) 1987-1991.
13. G. A. Mc Clelland, S. C. Sutton, K. Engle and G. M. Zentner, The solubility- modulated osmotic pump: in vitro/in vivo release of diltiazem hydrochloride, Pharm. Res. 8 (1991) 88-92.
14. S. Rose and J. F. Nelson, A continuous long-term injector, Austral. J. Exp. Biol. 33 (1995) 415-420.
15. G. Zentner, G. Rork and K. Himmelstein, The controlled porosity osmotic pump, J. Contr. Rel. 1 (1985) 269-282.
16. M. Rani and B. Mishra, Comparative evaluation of in vitro performance of commercial and fabricated sustained release diclofenac sodium tablets, Ind. J. Pharm. Sci. 63 (2001) 247-250.
17. M. Rani and B. Mishra, Effect of admixed polymers on diclofenac sodium release from matrix tablets, Pharm. Pharmacol. Lett. 11 (2001) 76-78.
18. M. Rani and B. Mishra, Development and evaluation of carbomer based matrices for the controlled delivery of diclofenac sodium, Acta Pharm. Turc. 45 (2003) 5-10.
19. G. Garcia-Encina, D. Torres, B. Seijo and J. L. Vila Jato, Formulation and in vitro evaluation of HPMCP-microencapsulated drug-resin complexes for sustained release of diclofenac, Int. J. Pharm. 121 (1995) 239-243.
20. E. A. Hosny, A. R. M. Al-Helw and M. A. Al-Dardiri, Comparative study of in vitro release and bioavailability of sustained release diclofenac sodium from certain hydrophilic polymers and commercial tablets in beagle dogs, Pharm. Acta Helv. 72 (1997) 159-164.
21. T Nishihata, Simple formulation of sustained release tablets of diclofenac and examination in humans, Int. J. Pharm. 40 (1987) 125-128.
22. M. T. Sheu, H. L. Chou, C. C. Kao, C. H. Liu and T. D. Sokoloski, Dissolution of diclofenac sodium from matrix tablets, Int. J. Pharm. 85 (1992) 57-63.
23. B. Mishra, J. Panyam and A. V. Sharma, In vitro release of diclofenac sodium from multiple emulsions; effect of location of drug and pH of the aqueous phase, Acta Pharm. Turc. 41 (1999) 42-45.
24. C. H. Liu, Y. H. Kao, S. C. Chen, T. D. Sokoloski and M. T. Sheu, In vitro and in vivo studies of the diclofenac sodium controlled-release matrix tablets, J. Pharm. Pharmacol. 47 (1995) 360-364.
25. C. Sajeev, G. Vinay, R. Archna and R. N. Saha, Oral controlled release formulation of diclofenac sodium by microencapsulation with ethyl cellulose, J. Microencap. 19 (2002) 753-760.
26. N. Ramakrishna and B. Mishra, Plasticizer effect and comparative evaluation of cellulose acetate and ethylcellulose-HPMC combination coatings as semipermeable membranes for oral osmotic pumps of naproxen sodium, Drug Dev. Ind. Pharm. 28 (2002) 403-412.
27. United States Pharmacopoeia 24, National Formulary 19 United States Pharmacopoeial Convention, Inc., Rockville 2001, pp. 2051.
28. G. Giagoudakis and S. L. Markantonis, An alternative high-performance liquid-chromatographic method for the determination of diclofenac and flurbiprofen in plasma, J. Pharm. Biomed. Anal. 17 (1998) 897-901.
29. M. A. Ramadan and R. Tawashi, Effect of hydrodynamic conditions and delivery orifice size on the rate of drug release from elementry osmotic pump system (EOP), Drug Dev. Ind. Pharm. 13 (1987) 235-248.
30. J. P. Skelly, L. A. Yamamoto, V. P. Shah, M. K. Yau and W. H. Barr, Topographical dissolution characterization for controlled release products: new technique, Drug Dev. Ind. Pharm. 12 (1986) 1159-1175.
31. J. P. Skelly, M. K. Yau, J. S. Elkins, L. A. Yamamoto, V. P. Shah and W. H. Barr, In vitro topographical characterization as a predictor of in vivo controlled release quindine gluconate bioavailability, Drug Dev. Ind. Pharm. 12 (1986) 1177-1201.
32. C. Sankar, M. Rani, A. K. Srivastava and B. Mishra, Chitosan based pentazocine microspheres for intranasal systemic delivery; development and biopharmaceutical evaluation, Pharmazie 56 (2001) 223-226,
33. W. Reiss, H. Sterlin, P. Degen, J. W. Faigle, A. Faigle, A. Geradin, J. Mopper, A. Sallman, A. Schmin, A. Schweizer, M. Sule, W. Thesbald and J. Wagner, Pharmacokinetics and metabolism of the anti-inflammatory agent voltaren, Scand. J. Rheumatol, 22 (1978) 17-29.
34. G. Levy, J. Leonards and J. A. Procknal, Development of in vitro tests which correlate quantitatively with dissolution rate limited drug absorption in man, J. Pharm. Sci. 54 (1965) 1719-1722.
35. V. P. Shah, V. K. Prasad, T. Alston, B. Cabina, R. P. Gural and M. C. Meyer, Phenytoin I: in vitro correlation for 100 mg phenytoin sodium capsules, J. Pharm. Sci. 72 (1983) 306-308.